CNS LESION
Clinical trials for CNS LESION explained in plain language.
Never miss a new study
Get alerted when new CNS LESION trials appear
Sign up with your email to follow new studies for CNS LESION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Gadolinium-Free MRI dye could make brain scans safer
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, which does not contain gadolinium, in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions compared to standard gado…
Matched conditions: CNS LESION
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated May 17, 2026 04:12 UTC
-
New MRI dye could sharpen brain scan images
Diagnosis CompletedThis study tested a new contrast agent called gadopiclenol to see if it makes brain and spine MRI scans clearer. 260 adults with known or suspected brain lesions received an MRI with and without the agent. The goal was to see if the enhanced images helped doctors better see lesio…
Matched conditions: CNS LESION
Phase: PHASE3 • Sponsor: Guerbet • Aim: Diagnosis
Last updated May 15, 2026 12:03 UTC